Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease - PubMed (original) (raw)

Comparative Study

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

C D Smith et al. Proc Natl Acad Sci U S A. 1991.

Abstract

The relationship between Alzheimer disease (AD) and aging is not currently known. In this study, postmortem frontal- and occipital-pole brain samples were obtained from 16 subjects with AD, 8 age-matched controls, and 5 young controls. These samples were analyzed both for protein oxidation products (carbonyl) and the activities of two enzymes vulnerable to mixed-function oxidation, glutamine synthetase and creatine kinase. Glutamine synthetase is more sensitive to mixed-function oxidation than creatine kinase. Carbonyl content rises exponentially with age, at double the rate in the frontal pole compared with the occipital pole. Compared with young controls, both aged groups (AD and age-matched controls) have increased carbonyl content and decreased glutamine synthetase and creatine kinase activities, which are more marked in the frontal than occipital pole in all instances. We conclude that protein oxidation products accumulate in the brain and that oxidation-vulnerable enzyme activities decrease with aging in the same regional pattern (frontal more affected than occipital). However, only glutamine synthetase activity distinguishes AD from age-matched controls: Because glutamine synthetase activity is differentially reduced in the frontal pole in AD, we suggest that AD may represent a specific brain vulnerability to age-related oxidation.

PubMed Disclaimer

Cited by

Protein Oxidation in Aging and Alzheimer's Disease Brain.
Sultana R, Butterfield DA. Sultana R, et al. Antioxidants (Basel). 2024 May 7;13(5):574. doi: 10.3390/antiox13050574. Antioxidants (Basel). 2024. PMID: 38790679 Free PMC article. Review.
Memory Recovery Effect of a New Bioactive Innovative Combination in Rats with Experimental Dementia.
Tancheva L, Kalfin R, Minchev B, Uzunova D, Tasheva K, Tsvetanova E, Georgieva A, Alexandrova A, Stefanova M, Solak A, Lazarova M, Hodzhev Y, Grigorova V, Yarkov D, Petkova-Kirova P. Tancheva L, et al. Antioxidants (Basel). 2023 Nov 28;12(12):2050. doi: 10.3390/antiox12122050. Antioxidants (Basel). 2023. PMID: 38136170 Free PMC article.
The Effect of Fat Intake with Increased Omega-6-to-Omega-3 Polyunsaturated Fatty Acid Ratio in Animal Models of Early and Late Alzheimer's Disease-like Pathogenesis.
Galeano P, de Ceglia M, Mastrogiovanni M, Campanelli L, Medina-Vera D, Campolo N, Novack GV, Rosell-Valle C, Suárez J, Aicardo A, Campuzano K, Castaño EM, Do Carmo S, Cuello AC, Bartesaghi S, Radi R, Rodríguez de Fonseca F, Morelli L. Galeano P, et al. Int J Mol Sci. 2023 Nov 30;24(23):17009. doi: 10.3390/ijms242317009. Int J Mol Sci. 2023. PMID: 38069333 Free PMC article.
The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
Chhimpa N, Singh N, Puri N, Kayath HP. Chhimpa N, et al. J Alzheimers Dis. 2023;94(s1):S453-S472. doi: 10.3233/JAD-220514. J Alzheimers Dis. 2023. PMID: 37393492 Free PMC article. Review.
Methionine Sulfoxide Reductases Suppress the Formation of the [PSI+] Prion and Protein Aggregation in Yeast.
Schepers J, Carter Z, Kritsiligkou P, Grant CM. Schepers J, et al. Antioxidants (Basel). 2023 Feb 7;12(2):401. doi: 10.3390/antiox12020401. Antioxidants (Basel). 2023. PMID: 36829961 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3633-6 - PubMed
1. Arch Gerontol Geriatr. 1991 Mar-Jun;12(2-3):155-77 - PubMed
1. Biochemistry. 1990 Jul 10;29(27):6323-31 - PubMed
1. J Neurol Sci. 1990 Aug;98(1):63-79 - PubMed
1. Mayo Clin Proc. 1988 Apr;63(4):390-408 - PubMed

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease - PubMed (original) (raw)